SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-12-328671
Filing Date
2012-08-01
Accepted
2012-08-01 15:50:34
Documents
1
Group Members
JAMES NIEDELJEANI DELAGARDELLENEW LEAF VENTURE ASSOCIATES II, L.P.NEW LEAF VENTURE MANAGEMENT II, L.L.C.PHILIPPE O. CHAMBONRONALD HUNTSRINIVAS AKKARAJUVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d388540dsc13d.htm SC 13D 203286
  Complete submission text file 0001193125-12-328671.txt   205158
Mailing Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 (646) 871-6400
New Leaf Ventures II, L.P. (Filed by) CIK: 0001441439 (see all company filings)

IRS No.: 320214549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86923 | Film No.: 121000044
SIC: 2834 Pharmaceutical Preparations